ertapenem has been researched along with Sepsis in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 10 (66.67) | 24.3611 |
2020's | 3 (20.00) | 2.80 |
Authors | Studies |
---|---|
Baek, S; Hwang, JE; Jeong, H; Jo, YH; Kang, JH; Kim, D; Kim, S; Kwon, H; Lee, JH; Park, I; Park, SJ | 1 |
Bai, Y; Fan, X; Fu, L; Tian, C; Wang, S; Xing, M; Zhao, Y | 1 |
Akbulut, I; Akkoçlu, G; Diniz, G; Göl Serin, B; Köse, Ş; Serin Senger, S; Serin, S; Yildirim, M; Yilmaz, O | 1 |
Blackmore, TK; Bloomfield, MG; Studd, RC; Wilson, AD | 1 |
Almirante, B; Campany, D; Fàbrega, A; Fox, ML; González-López, JJ; Larrosa, N; Miguel, L; Mir, A; Piedra-Carrasco, N; Ruiz-Camps, I; Viñado, B | 1 |
Gong, S; Hu, X; Jiang, Y; Li, J; Shang, X; Yu, R; Zhang, X; Zhang, Y | 1 |
Blackmore, T; Losco, G; Studd, R | 1 |
Cipolla, A; D'Abramo, A; D'Agostino, C; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Tierno, F; Trinchieri, V; Vullo, V | 1 |
Jeon, YL; Kang, SY; Kim, MH; Lee, MY; Lee, WI | 1 |
Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Cisneros, JM; García-Vázquez, E; Gasch, O; Giamarellou, H; Gracia-Ahulfinger, I; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Mora-Rillo, M; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Schwaber, MJ; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P | 1 |
Brink, AJ; Kiem, S; Richards, GA; Schentag, J; Schillack, V | 1 |
Abdul-Baki, H; Aoun, E; Chaar, HF; El Hajj, II; Hashash, JG; Kanj, SS; Kyriacos, SB; Mansour, NM; Mroueh, M; Sharara, AI | 1 |
Boselli, E; Breilh, D; Fleureau, C; Gordien, JB; Janvier, G; Joanes-Boyau, O; Rapaport, S; Saux, MC; Texier-Maugein, J | 1 |
Corona, A; Singer, M | 1 |
Apolônio, ACM; Carvalho, MAR; Coutinho, SC; Diniz, CG; Farias, LM; Martins, WA; Nicoli, JR; Santos, KVD | 1 |
2 trial(s) available for ertapenem and Sepsis
Article | Year |
---|---|
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Survival Analysis; Treatment Outcome | 2016 |
Prophylaxis with ertapenem in patients with obstructive jaundice undergoing endoscopic retrograde cholangiopancreatography: safety, efficacy, and biliary penetration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biliary Tract; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Ertapenem; Female; Humans; Jaundice, Obstructive; Male; Middle Aged; Sepsis; Young Adult | 2011 |
13 other study(ies) available for ertapenem and Sepsis
Article | Year |
---|---|
Changes in Biomarkers and Hemodynamics According to Antibiotic Susceptibility in a Model of Bacteremia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Biomarkers; Ertapenem; Escherichia coli; Hemodynamics; Male; Sepsis; Swine; Triggering Receptor Expressed on Myeloid Cells-1 | 2022 |
Whole genome sequencing of OXA-232-producing
Topics: Amikacin; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromosomes; Ciprofloxacin; DNA Transposable Elements; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis; Virulence; Virulence Factors; Whole Genome Sequencing | 2022 |
An evaluation of the effect of ertapenem in rats with sepsis created by cecal ligation and puncture.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Ertapenem; Peritonitis; Random Allocation; Rats; Rats, Wistar; Sepsis | 2019 |
Highly effective prophylaxis with ertapenem for transrectal ultrasound-guided prostate biopsy: effects on overall antibiotic use and inpatient hospital exposure.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Cross Infection; Ertapenem; Hospitals; Humans; Injections, Intramuscular; Inpatients; Male; Middle Aged; Prostate; Prostatic Neoplasms; Rectum; Sepsis; Ultrasonography, Interventional | 2020 |
Effectiveness of a Double-Carbapenem Regimen in a KPC-Producing Klebsiella pneumoniae Infection in an Immunocompromised Patient.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; beta-Lactams; Drug Combinations; Ertapenem; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Sarcoma, Myeloid; Sepsis; Thienamycins; Transplantation, Homologous; Treatment Outcome | 2018 |
Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis.
Topics: Ertapenem; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella pneumoniae; Quinolones; Sepsis; Shock, Septic; Urinary Tract Infections | 2019 |
Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Ertapenem; Escherichia coli Infections; Humans; Male; Middle Aged; Patient Selection; Prospective Studies; Prostatic Neoplasms; Rectum; Risk Assessment; Risk Factors; Sepsis; Surveys and Questionnaires; Treatment Outcome; Ultrasonography, Interventional | 2014 |
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sepsis; Thienamycins | 2016 |
A Case of Sepsis in a 92-Year-Old Korean Woman Caused by Aerococcus urinae and Identified by Sequencing the 16S Ribosomal RNA Gene.
Topics: Aerococcus; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Meropenem; Remission Induction; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, RNA; Thienamycins; Urinary Tract Infections | 2016 |
Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Chromatography, High Pressure Liquid; Cohort Studies; Critical Illness; Ertapenem; Female; Humans; Male; Middle Aged; Plasma; Prospective Studies; Sepsis; Time Factors; Urine; Young Adult | 2009 |
Pharmacokinetics of free ertapenem in critically ill septic patients: intermittent versus continuous infusion.
Topics: Aged; Anti-Bacterial Agents; Bacteria; beta-Lactams; Critical Illness; Ertapenem; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis | 2011 |
An epistemological dilemma: is ertapenem adequate to treat severe infections in critically ill patients?
Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Humans; Male; Sepsis | 2011 |
Comparative activity of ertapenem and piperacillin tazobactam in a murine systemic infection model with Bacteroides fragilis and Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Blood; Colony Count, Microbial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2007 |